BETTERLIFE PHARMA INC. Sales And Marketing Expense
BETTERLIFE PHARMA INC. (BETRF) reported Sales And Marketing Expense of CAD 0 for the 12-month period ending 2025-01-31, per its 20-F filed 2025-06-02.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:SalesAndMarketingExpense · last filed 2025-06-02
| Period end | Sales And Marketing Expense 12 month |
|---|---|
| 2025-01-31 | 0.00 CAD 20-F · filed 2025-06-02 |
| 2024-01-31 | 0.00 CAD 20-F · filed 2025-06-02 |
| 2023-01-31 | 123.22K CAD 20-F · filed 2025-06-02 |